-
Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
2025-12-24
In order to support the export trade of pharmaceutical products and strengthen the management of inspection and export certificate for exported pharmaceutical products of pharmaceutical manufacturers, the National Medical Products Administration has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, which is hereby promulgated and shall come into force as of January 1, 2026.
-
Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
2025-12-24
In order to implement the spirit of "Supporting the Export Trade of Drugs and Medical Devices" outlined in the Opinions of the General Office of the State Council on Comprehensively Deepening the Reform of the Regulation of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry (GBF [2024] No. 53), the National Medical Products Administration (NMPA) has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, (hereinafter referred to as the "Provisions").
-
Announcement of the National Medical Products Administration on the Release of the Good Manufacturing Practice for Medical Devices ([2025] No. 107)
2025-12-24
To strengthen the quality management of medical device manufacturing, regulate medical device manufacturing activities, promote normative development of the industry, and ensure the safety and effectiveness of medical devices for public use, the National Medical Products Administration has revised the Good Manufacturing Practice for Medical Devices in accordance with the Regulations for the Supervision and Administration of Medical Devices and the Provisions for Supervision and Administration of Medical Device Manufacturing.
-
Requirements for the Pilot Program of Electronic Labels for Cosmetics
2025-12-24
To regulate the pilot program for electronic labels for cosmetics (including toothpaste, hereinafter referred to as "cosmetics"), these Requirements are formulated in accordance with the provisions of the Regulations on Supervision and Administration of Cosmetics (hereinafter referred to as the "Regulations"), the Provisions for Registration and Filing of Cosmetics, the Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics, the Provisions for Toothpaste Regulation, and the Measures for the Administration of Cosmetics Labels.
-
NMPA’s Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-Quality Industry Development
2025-12-22
To further coordinate high-quality development and high-level safety in the cosmetics sector, and thereby better meet the people's new expectations for a better life in the new era, the following opinions are proposed to deepen the reform of cosmetics regulation and promote the high-quality development of the cosmetics industry.
-
Policy Interpretation of the NMPA’s Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-Quality Industry Development
2025-12-22
To thoroughly implement the important instructions of General Secretary Xi Jinping on drug regulation and industrial development, further coordinate high-quality development and high-level safety in the cosmetics sector, and thereby better meet the people's new expectations for a better life in the new era, the NMPA has issued the NMPA's Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-Quality Industry Development (hereinafter referred to as the Opinions). The key points are interpreted as follows.